We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 28 Jul 2015
Top-of-the-line automated diagnostic systems are highlighted in Booth 2409 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

Beckman Coulter Diagnostics (Brea, CA, USA) is displaying its state-of-the-art laboratory instruments at this year's meeting. More...
Particular emphasis is being placed on the Power Express automation system for general clinical chemistry and the MicroScan WalkAway system for the microbiology lab.

Power Express is a connected clinical automation solution that consolidates all core disciplines—chemistry, immunochemistry, hematology, and coagulation—into a single automated line. Power Express performs multiple functions including sample login, centrifugation, decapping, aliquotting, presentation of samples for connected instruments, recapping, storing in ambient or refrigerated storage modules, and sorting to outlets. Intelligent sample management reduces variability and increases predictability because dynamic sample routing is based on test ordered and analyzers availability. Samples can crisscross and loop-back on track to analyzers, and smart carrier management ensures that high-throughput analyzers are optimized. Barcode sample reading at each sample aspiration maintains accuracy with positive patient identification.

The WalkAway plus microbiology system is the fourth generation of proven WalkAway technology and reliability. This platform delivers gold-standard accuracy for microorganism identification and susceptibility testing. It enables simultaneous processing of conventional, rapid, and specialty panels on a single, automated platform and delivers accurate resistance detection for emerging pathogens, including VISA, VRSA, and MRSA. The WalkAway plus System includes LabPro Information Management software designed to simplify workflow and minimize technologist interaction while accommodating differing regional and institutional environments through extensive customization features.

Visitors to the Beckman Coulter Diagnostics booth will be shown how the company is helping laboratories balance better patient care and efficiency to achieve goals such as standardized processes to achieve increased capacity while minimizing errors and reducing turnaround time to improve physician confidence.

“The American Association of Clinical Chemistry Annual Meeting allows us the opportunity to share with the diverse diagnostics laboratory industry how we partner to move healthcare forward,” said Arnd Kaldowski, president of Beckman Coulter Diagnostics. “This year, we are particularly eager to share our newest product offerings and demonstrate to laboratories in a unique, interactive way, how with personalized, expert attention, clinical data management tools and the Danaher Business System, laboratories can to drive continuous improvement and sustainment in today’s healthcare landscape.”

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
Beckman Coulter Diagnostics 



New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image:Schematic illustration of plasmonic microarray–based KRAS mutation detection from colorectal cancer patients. (Lee, J.Y., Mun, C.W., Kim, E.R. et al. npj Precision Oncology, 2026. https://doi.org/10.1038/s41698-026-01452-8)

Blood and Urine Liquid Biopsy Detects Early Colorectal Cancer Mutations

Early-stage colorectal cancer is difficult to assess noninvasively because tumor-derived mutations occur at extremely low levels in blood and urine, straining the sensitivity, cost, and turnaround time... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.